HER3 (ERBB3) amplification in liposarcoma - a putative new therapeutic target?Ann-Katharina Becker(RWTH Aachen University), Till Braunschweig(Ludwig-Maximilians-Universität München)World Journal of Surgical OncologyMay 17, 202410.1186/s12957-024-03406-5Cited by 0SaveCiteExport RISWatch citationsRelated PapersCredentialing Preclinical Pediatric Xenograft Models Using Gene Expression and Tissue Microarray Analysis|Cancer Research|2007|110Elevated levels of circulating osteopontin are associated with a poor survival after resection of cholangiocarcinoma|Journal of Hepatology|2017|77